Y. Peter Li
Directeur/Membre du Conseil chez NiKang Therapeutics, Inc.
Provenance du réseau au premier degré de Y. Peter Li
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
NiKang Therapeutics, Inc.
 NiKang Therapeutics, Inc. BiotechnologyHealth Technology NiKang Therapeutics, Inc. operates as biotechnology company. It focuses on developing novel small molecule oncology drug discovery. The company was founded by Zhenhai Gao and is headquartered in Wilmington, DE.
5
| Holding Company | Biotechnology | 5 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Y. Peter Li via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Davidson Kempner Capital Management LP
 Davidson Kempner Capital Management LP Investment ManagersFinance Davidson Kempner Capital Management LLC (DKCM) is an independent, SEC-registered investment advisor and hedge fund management firm headquartered in New York City. The firm was founded in 1983 by Marvin Davidson and Thomas Kempner Sr. DKCM provides investment advice and investment management services to private investment funds. | Investment Managers | Corporate Officer/Principal | |
| University of California, Berkeley | College/University | Undergraduate Degree | |
Sanofi-Aventis U.S. LLC
 Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Virginia | College/University | Corporate Officer/Principal | |
| Nankai University | College/University | Doctorate Degree | |
| University of Pennsylvania | College/University | Masters Business Admin | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal | |
CBC Group (Singapore) Pte. Ltd.
 CBC Group (Singapore) Pte. Ltd. Investment ManagersFinance CBC Group (Singapore) Pte. Ltd.(CBC Group) is a private equity firm founded in 2014 by Wei Fu. The firm is headquartered in Singapore with additional offices in New York, Hong Kong, Shanghai and Beijing and is wholly owned by CBC Group Investment Management Ltd. | Investment Managers | Director/Board Member | |
| EVEREST MEDICINES LIMITED | Pharmaceuticals: Major | Chief Executive Officer | |
ENSEM Therapeutics, Inc.
 ENSEM Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ENSEM Therapeutics, Inc. is a drug discovery and development company that specializes in developing small molecule precision medicines for oncology. The company is based in Waltham, MA. The company leverages its unique Kinetic Ensemble® platform to develop innovative drugs. The company has a potential oral CDK2 inhibitor, PI3K?, and a number of early-stage discovery programs at various stages of maturity launched with their Kinetic Ensemble® platform. ENSEM Therapeutics was founded by Shenfang Jin, Qi Zhang, Cheng Luo, and Shenfang Jin has been the CEO since incorporation. | Pharmaceuticals: Major | Chief Executive Officer | |
| University of California, Los Angeles | College/University | Masters Business Admin | |
| The University of Chicago | College/University | Corporate Officer/Principal | |
| AMBRX INC | Pharmaceuticals: Major | Director of Finance/CFO | |
| ANNEXON, INC. | Pharmaceuticals: Major | Private Equity Investor | |
| GUARDANT HEALTH, INC. | Medical/Nursing Services | Private Equity Investor | |
| ERASCA, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
Xilis, Inc.
 Xilis, Inc. Medical SpecialtiesHealth Technology Xilis, Inc. engages in the development of droplet-based microfluidics technology devices for precision cancer diagnostics and drug development. It offers Xilis platform. The company was founded by Xiling Shen and David Shu and is headquartered in Durham, NC. | Medical Specialties | Director of Finance/CFO | |
| Stanford School of Medicine | College/University | Consultant / Advisor | |
Stealth Startup Solutions LLC
 Stealth Startup Solutions LLC Miscellaneous Commercial ServicesCommercial Services Stealth Startup Solutions LLC engages in provision of consulting services. The company is headquartered in San Francisco, CA. | Miscellaneous Commercial Services | Founder | |
Ggtg Biosciences, Inc.
 Ggtg Biosciences, Inc. Investment ManagersFinance GGTG Biosciences Inc (GGTG Biosciences) is a venture capital firm founded in 2022 by Gary Yeung. The firm is headquartered in Burlingame, California. | Investment Managers | Chief Executive Officer | |
Berkeley Frontier Fund
 Berkeley Frontier Fund Investment ManagersFinance Berkeley Frontier Fund (Berkeley Frontier Fund) is a venture capital firm founded in 202. The firm is headquartered in Berkeley, California. | Investment Managers | Consultant / Advisor | |
New Leaf Venture Partners LLC
 New Leaf Venture Partners LLC Investment ManagersFinance New Leaf Venture Partners LLC (New Leaf Ventures) is an independent Venture Capital firm founded by Jeani Delagardelle, Philippe Chambon, Vijay Lathi, Ron Hunt, James Niedel, and Kathy LaPorte. The firm is headquartered in New York. It spun out from Sprout Group. | Investment Managers | Private Equity Analyst | |
| Kalobios Pharmaceuticals, Inc. | Corporate Officer/Principal | ||
RTW Investments LP
 RTW Investments LP Investment ManagersFinance RTW Investments LP (RTW) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Dr. Roderick Wong in 2010. RTW provides discretionary advisory services to various RTW Funds. | Investment Managers | Chief Executive Officer | |
RTW Investments /Venture/
 RTW Investments /Venture/ Investment ManagersFinance RTW Investments /Venture/ (RTW Investments) is a venture capital subsidiary of RTW Investments LP founded in 2009 by Roderick Wong. The firm is headquartered in New York. | Investment Managers | Chief Investment Officer | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree | |
| ROCKET PHARMACEUTICALS, INC. | Biotechnology | Chairman | |
Attune Pharmaceuticals, Inc.
 Attune Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Attune Pharmaceuticals, Inc. engages in the provision of biotechnology services. It discovers and develops orally-administered small-molecule therapeutics for the treatment of rare diseases. The company was founded by Andrew Ian McDonald and is headquartered in New York, NY. | Miscellaneous Commercial Services | Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin | |
| Perelman School of Medicine | College/University | Doctorate Degree | |
| LANDOS BIOPHARMA, INC. | Biotechnology | Director/Board Member | |
| AVIDITY BIOSCIENCES, INC. | Biotechnology | Director/Board Member | |
Jixing Pharmaceutical Technology (Shanghai) Co. Ltd.
 Jixing Pharmaceutical Technology (Shanghai) Co. Ltd. Pharmaceuticals: MajorHealth Technology Jixing Pharmaceutical Technology (Shanghai) Co. Ltd. is a Chinese company that develops and commercializes novel therapeutics. Yan Ping Mou has been the CEO of the company since 2023. | Pharmaceuticals: Major | Director/Board Member | |
| EXELIXIS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Rocket Pharmaceuticals Ltd.
 Rocket Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Rocket Pharmaceuticals Ltd. operates as a biotechnology company which focuses on developing gene therapy treatment for undertreated diseases. The firm’s pipeline includes Fanconi Anemia, Pyruvate Kinase Deficiency, Leukocyte Adhesion Deficiency-1 and Infantile Malignant Osteopetrosis. It also develops an AAV-based therapy program for an undisclosed rare pediatric disease. The company is headquartered in New York, NY. | Pharmaceuticals: Major | Chairman | |
| University of Illinois | College/University | Undergraduate Degree | |
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal | |
| HUMANIGEN, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| Stritch School of Medicine | College/University | Doctorate Degree | |
| JAZZ PHARMACEUTICALS PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| NEXTCURE, INC. | Pharmaceuticals: Major | Director/Board Member | |
Talon Therapeutics, Inc.
 Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| CURIS, INC. | Biotechnology | Director/Board Member | |
| SUTRO BIOPHARMA, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Duke Capital Partners LLC
 Duke Capital Partners LLC Investment ManagersFinance Duke Capital Partners, LLC provides financial advisory, investment, and equity services. The company was founded in 2000, and is headquartered in Charlotte, NC. | Investment Managers | Corporate Officer/Principal |
Statistiques
Internationale
| Etats-Unis | 44 |
| Chine | 4 |
| Singapour | 2 |
| Irlande | 2 |
Sectorielle
| Health Technology | 24 |
| Consumer Services | 13 |
| Finance | 10 |
| Commercial Services | 3 |
| Health Services | 2 |
Opérationnelle
| Director/Board Member | 14 |
| Corporate Officer/Principal | 13 |
| Chief Executive Officer | 6 |
| Founder | 5 |
| Independent Dir/Board Member | 4 |
Relations les plus connectées
| Insiders | |
|---|---|
| Rod Wong | 15 |
| Anne Borgman | 13 |
| Gary Yeung | 13 |
| Sean Cao | 11 |
| Zhenhai Gao | 1 |
- Bourse
- Insiders
- Y. Peter Li
- Connexions Sociétés
